Observational study / 2018
Total antibody responses against red meat-derived Neu5Gc-glycans were positively associated with colorectal cancer risk.
Researchers evaluated antibody levels against red meat-derived Neu5Gc and Neu5Gc-glycans in samples from the Nurses' Health Studies, HPFS, and EPIC. ELISA assays showed reproducible antibody responses, but levels did not correlate with coronary artery disease risk, red meat intake, or colorectal cancer (CRC) risk for individual epitopes. However, when total antibody responses against all Neu5Gc-glycans were combined via a sialoglycan microarray, individuals in the top quartile of total anti-Neu5Gc IgG concentrations had an increased risk of CRC compared to the bottom quartile (multivariate OR: 2.98, 95% CI: 0.80, 11.1; P for trend = 0.02).
Shows an association, not proof of cause and effect.
- Study type
- Nested case-control and prospective biomarker evaluation study
- Who was studied
- Participants from Nurses' Health Studies, HPFS, and EPIC
- What was measured
- Coronary artery disease risk, red meat intake, and colorectal cancer risk
THE PAPER
Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk.
Samraj AN, Bertrand KA, Luben R, Khedri Z, Yu H, Nguyen D, Gregg CJ, Diaz SL, Sawyer S, Chen X, Eliassen H, Padler-Karavani V, Wu K, Khaw KT, Willett W, Varki A. PLoS One, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.